exosomes from mesenchymal stem cells Report issue

Vaccine Experimental
AACT

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

exosomes from mesenchymal stem cells

Organizations (12)

Research & Development (12)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (14)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (14)


 

Alzheimer Disease (Phase 1/Phase 2)

Coronavirus (Phase 1)

COVID-19 (Phase 2)

Crohn Disease (Phase 1)

Dyspnea (Phase 1/Phase 2)

Healthy Volunteers (Phase 1)

Infections (Phase 1/Phase 2)

Irritable Bowel Syndrome (Phase 1)

Osteoarthritis, Knee (Phase 1)

Periodontitis (Early Phase 1)

Pharmacology (Phase 1/Phase 2)

Pneumonia (Phase 1/Phase 2)

Respiratory Distress Syndrome (Phase 1/Phase 2)

Retinal Perforations (Early Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 22
  • # of Trial Organizations: 12

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue